Camilla Sandberg
Chief Executive Officer bij MIRIS HOLDING AB
Actieve functies van Camilla Sandberg
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MIRIS HOLDING AB | Chief Executive Officer | 04-10-2016 | - |
NEXTCELL PHARMA AB | Director/Board Member | 01-01-2017 | - |
Independent Dir/Board Member | 01-01-2017 | - | |
MONIVENT AB | Director/Board Member | - | - |
Independent Dir/Board Member | - | - |
Loopbaan van Camilla Sandberg
Eerdere bekende functies van Camilla Sandberg
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Sales & Marketing | - | - |
Opleiding van Camilla Sandberg
University of Oslo | Masters Business Admin |
Statistieken
Internationaal
Zweden | 5 |
Noorwegen | 2 |
Operationeel
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 4 |
Electronic Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
MIRIS HOLDING AB | Electronic Technology |
MONIVENT AB | Health Technology |
NEXTCELL PHARMA AB | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Health Technology |
- Beurs
- Insiders
- Camilla Sandberg
- Ervaring